
News|Articles|December 1, 2012
SSRIs risky during pregnancy and affect neonatal health
There is evidence of risk with the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and to neonatal health and beyond, according to a study published in Human Reproduction.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
2
CGM prescribed by primary care lowers A1C and acute care use in diabetes patients
3
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
4
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
5


























